Description

4-(1,3-Benzoxathiol-2-Yl)-α-Methylbenzeneacetic Acid is a specialized organic compound featuring a benzoxathiole moiety linked to a methylbenzeneacetic acid structure. This unique molecular architecture makes it a valuable intermediate and building block in advanced organic synthesis, particularly for developing novel active pharmaceutical ingredients (APIs) and functional materials. It is primarily sought by pharmaceutical R&D teams and fine chemical manufacturers engaged in the development of new therapeutic agents and high-value specialty chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or possessing anti-inflammatory properties.
• Organic Synthesis Building Block: Used in complex multi-step syntheses to construct heterocyclic compounds and other advanced molecular frameworks.
• Agrochemical Research: Serves as a starting material for developing new active ingredients for crop protection products.
• Material Science: Potential intermediate in the creation of specialty polymers or organic electronic materials due to its conjugated system.
• Chemical Research & Development: Employed in academic and industrial labs for methodological studies and the exploration of new chemical reactions.

Basic Information

Product Name	4-(1,3-Benzoxathiol-2-Yl)-α-Methylbenzeneacetic Acid
CAS No.	52787-33-4
Molecular Formula	C16H14O3S
Molecular Weight	286.35 g/mol
Synonyms	2-[4-(1,3-Benzoxathiol-2-yl)phenyl]propanoic acid; α-Methyl-4-(1,3-benzoxathiol-2-yl)benzeneacetic acid; 4-(2,3-Dihydro-1,4-benzoxathiin-2-yl)hydratropic acid (related structure); Benzoxathiole-2-propanoic acid derivative; 2-(4-(Benzo[d][1,3]oxathiol-2-yl)phenyl)propanoic acid; 52787-33-4; 4-(1,3-Benzoxathiolan-2-yl)-α-methylbenzenacetic acid
EINECS	Contact for details

Quality Control

Our production of 4-(1,3-Benzoxathiol-2-Yl)-α-Methylbenzeneacetic Acid adheres to stringent quality protocols to ensure batch-to-batch consistency and high purity. All materials are subjected to comprehensive analytical testing, including HPLC, NMR, and IR spectroscopy. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment. We support cGMP compliance for pharmaceutical applications and can tailor specifications to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from strong acids and organic solvents. The container should be kept tightly sealed in a dry environment to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.